The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
Open accessAbstract
Stem-cell fate can be influenced by metabolite levels in culture, but it is not known whether physiological variations in metabolite levels in normal tissues regulate stem-cell function in vivo. Here we describe a metabolomics method for the analysis of rare cell populations isolated directly from tissues and use it to compare mouse haematopoietic stem cells (HSCs) to restricted haematopoietic progenitors. Each haematopoietic cell type had a distinct metabolic signature. Human and mouse HSCs had unusually high levels of ascorbate, which decreased with differentiation. Systemic ascorbate depletion in mice increased HSC frequency and function, in part by reducing the function of Tet2, a dioxygenase tumour suppressor. Ascorbate depletion cooperated with Flt3 internal tandem duplication (Flt3 ITD) leukaemic mutations to accelerate leukaemogenesis, through cell-autonomous and possibly non-cell-autonomous mechanisms, in a manner that was reversed by dietary ascorbate. Ascorbate acted cell-autonomously to negatively regulate HSC function and myelopoiesis through Tet2-dependent and Tet2-independent mechanisms. Ascorbate therefore accumulates within HSCs to promote Tet activity in vivo, limiting HSC frequency and suppressing leukaemogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ascorbate deficiency was shown to dysregulate HSC function in both a TET2-dependent and TET2-independent manner, leading to leukaemogenesis.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [72]
In the citing paper
“oral ascorbate may have a preventive role in leukaemogenesis72.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [72]
In the citing paper
“Using various GEMMs, including GULO-knockout mice, this study reveals that vitamin C is necessary for normal haematopoietic stem cell development and the prevention of leukaemia in mice.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [72]
In the citing paper
“Using various GEMMs, including GULO-knockout mice, this study reveals that vitamin C is necessary for normal haematopoietic stem cell development and the prevention of leukaemia in mice.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · cited 1×
“Tet enzymes convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), then catalyze some steps toward unmethylated cytosine 24,25 .”
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Moreover, clonal hematopoiesis of indeterminate potential is common among older humans and is often associated with loss of one Tet2 allele 45–47 .”
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451 · cited 1×
“Tet enzymes convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), then catalyze some steps toward unmethylated cytosine 24,25 .”
MetaboAnalyst 3.0—making metabolomics more meaningful
Xia, J., Sinelnikov, I. V., Han, B., & Wishart, D. S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv380 · Cited by 2,680 · cited 1×
“Metabolomics data analysis and hierarchical clustering were performed using MetaboAnalyst 54 and Simca (Umetrics).”
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,990 · cited 1×
“TET2 mutations cooperate with FLT3 ITD mutations to cause acute myeloid leukaemia (AMLs) 31,35 .”
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776 · cited 1×
“Tet2 inactivating mutations are early events in leukaemogenesis 26 that increase HSC frequency and self-renewal 27–29 and cause leukaemia when combined with other mutations 30–32 .”
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339 · cited 3×
“Consistent with prior studies 27–29 , conditional deletion of Tet2 in adult haematopoietic cells significantly increased HSC frequency and function (Extended Data Fig.”
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 555
Premnath, N., & Madanat, Y. F. (2023) · Cancers · doi:10.3390/cancers15112958 · Cited by 4
“Hematopoietic stem cells and brain cells contain some of the highest levels of vitamin C among human cells [105].”
BackgroundMetabolic Alterations in HSCs during Aging and Leukemogenesis
Chiang, Y.-H., Emmrich, S., & Vannini, N. (2025) · Physiology · doi:10.1152/physiol.00054.2024 · Cited by 6
Mutation-Driven Therapy in MDS
Swoboda, D. M., & Sallman, D. A. (2019) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-019-00554-4 · Cited by 5
Ação antioxidante e propriedades funcionais do morango no organismo humano
Nunes, G., & Novello, D. (2021) · Revista Valore · doi:10.22408/reva502020246e-5004 · Cited by 5
3022 – CELL SIZE IS A DETERMINANT OF STEM CELL POTENTIAL DURING AGING
Lengefeld, J., & Amon, A. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.12.244 · Cited by 4
Metabolic Regulations in Hematopoietic Stem Cells
Huang, D., Chen, C., Hao, X., Gu, H., Xie, L., Yu, Z., & Zheng, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7342-8_3 · Cited by 5
Clapes, T., & Trompouki, E. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000585 · Cited by 5
“TET2 function is inhibited by systemic ascorbate depletion and results in increased HSC frequency and function [22].”
BackgroundMicronutrient regulation of the DNA methylome
Leesang, T. E., Lyon, P. D., Pinzone, J., & Cimmino, L. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1409355 · Cited by 5
Luo, H., Gao, S., Zhen, C., Xiao, H., Cui, Y., & Wang, L. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115413 · Cited by 4
Urabe, A., Chi, S., & Minami, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043727 · Cited by 4
“Recent studies have suggested that vitamin C, a co-factor of TET proteins, negatively regulates HSC function and prevent leukemogenesis, at least partially due to enhanced TET activity [67,68].”
BackgroundWang, W., Villanueva, M. A., Mathews, T. P., DeVilbiss, A., Zhao, Z., Martin-Sandoval, M. S., Mohammed, A., Benegiamo, G., Awani, A., Goeminne, L. J. E., et al. (2024) · Blood · doi:10.1182/blood.2024024123 · Cited by 5
Self-citationClonal Hematopoiesis, a Risk Condition for Developing Myeloid Neoplasia
Testa, U., Castelli, G., & Pelosi, E. (2025) · Hemato · doi:10.3390/hemato6020010 · Cited by 5
Anticancer Effects of Ascorbic Acid: Not All Sides Fit All
Arunsi, U. O., Olugbami, J. O., & Oyelere, A. K. (2025) · Cancers · doi:10.3390/cancers17172877 · Cited by 4
Zhang, J.-L., Tong, S.-L., Zhuang, Q., Jin, S., Li, J., & Sun, J. (2025) · Military Medical Research · doi:10.1186/s40779-025-00654-8 · Cited by 6
“Vitamin C supplementation has been shown to enhance residual TET2 activity in TET2-mutant leukemia models, reversing aberrant DNA methylation and restraining leukemic stem cell proliferation, thereby delaying disease progression [177].”
Loss of vitamin C biosynthesis protects from the pathology of a parasitic infection
Chen, G., Jun, J. H., Wijshake, T., Kwarteng, E. O., Li, Y., Yuan, M., Rose, J., Li, S., Cobb, S. A., Serpa, W., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517730122 · Cited by 5
“Ascorbate regulates mammalian stem cell function, cell differentiation, and reproduction via DNA or histone methylation ( 8 , 10 , 43 , 44 ).”
InfluentialSelf-citationAlveolar epithelial TET2 is not involved in the development of bleomycin‐induced pulmonary fibrosis
Qin, W., Crestani, B., Spek, C. A., Scicluna, B. P., van der Poll, T., & Duitman, J. (2021) · The FASEB Journal · doi:10.1096/fj.202002686rr · Cited by 4
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation
Leesang, T. E., Brabson, J. P., Yap, Y. S., Barbieri, D. A., Klimas, A. S., Pinzone, J., Ahearn, E. L., Lam, M. Q., Lyon, P. D., Swirski, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116379 · Cited by 3
“Vitamin A deficiency has also been linked to impaired hematopoiesis and loss of HSC quiescence 23,80 that mimics the effect of ascorbate deficiency, which suppresses Tet2 activity in HSCs. 14 Given that haploinsufficient TET2 mutation is a driver of hematological cancers and imparts HSPCs with a competitive advantage,…”
InfluentialYang, Z., Huang, T., Li, F., Huang, W., Ouyang, X., Wu, K., & Hao, J. (2025) · Chemical Science · doi:10.1039/d5sc03207e · Cited by 3
Fu, D., Dong, Y., Yin, J., Zhang, B., Zhang, S., Deng, J., Shui, H., & Liu, X. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403454 · Cited by 3
The physiological functions of ascorbate in the development of cancer
Agathocleous, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052201 · Cited by 4
“I predict that ascorbate administration will benefit ascorbate-deficient individuals with clonal hematopoiesis, not by changing clonal competition but by preventing a TET-deficient state that collaborates with clonal hematopoiesis mutations (in TET2 or other genes) to cause leukemia or exacerbate inflammation.”
InfluentialSelf-citationSingh, R., Parchwani, D. N., Sharma, G., & Sharma, P. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-025-01341-0 · Cited by 3
“This molecule has an intriguing history of use in cancer treatment, marked by both anecdotal successes and considerable debates, particularly due to inconsistent reported outcomes from early pivotal clinical trials [18 – 20].”
Ang, A. D., Vissers, M. C. M., Burgess, E. R., Currie, M. J., & Dachs, G. U. (2021) · Antioxidants · doi:10.3390/antiox10030430 · Cited by 3
“We detected low intracellular levels of ascorbate in whole bone marrow mononuclear cells upon isolation (~0.4 nmol/million cells), in agreement with a previous report showing similar ascorbate levels in whole bone marrow leukocytes (~0.3 nmol/million cells) [49].”
InfluentialPrasad, M., Ghosh, M., & Kumar, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85062-9.00013-1 · Cited by 3
Approaches towards Elucidating the Metabolic Program of Hematopoietic Stem/Progenitor Cells
Kobayashi, H., Watanuki, S., & Takubo, K. (2022) · Cells · doi:10.3390/cells11203189 · Cited by 4
“Thus, the accumulation of ascorbate in HSCs increases Tet activity to limit HSC frequency and suppress leukemogenesis [51].”
BackgroundMashauri, H. L. (2023) · Health Science Reports · doi:10.1002/hsr2.1611 · Cited by 3
“Vitamin C deficiency impair hematopoiesis significantly and cause hypo‐cellular bone marrow which is associated with dysfunction and reduction in HSCs, multipotent progenitors, and hematopoietic progenitors.(18,19) Vitamin C supplementation have been found to suppress and reverse this effect.”
BackgroundInfluentialJin, W., Yao, H., Wang, X., Li, M., Gao, X., Chen, W., & Zhang, Y. (2025) · Journal of Materials Chemistry C · doi:10.1039/d4tc04412f · Cited by 3
Self-citationVitamins and dietary supplements in cancer treatment: is there a need for increased usage?
Esposito, T., Pentimalli, F., Giordano, A., & Cortellino, S. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2501077 · Cited by 4
“Recent investigations revealed that oral vitamin C supplementation may reactivate silenced tumor suppressor genes and enhance stem cell differentiation by promoting DNA promoter demethylation via TET enzyme activation [156,161,162].”
Vitcylation of Lysine: The Novel Mechanism of Vitamin C in Tumor Treatment
Li, J., Gu, A., Tang, N., Zhou, J., Li, C., Zengin, G., & Li, M. (2025) · BIO Integration · doi:10.15212/bioi-2025-0057 · Cited by 3
Covering the Stem Cell Explosion at the 2017 ISSCR Conference in Boston
Graf, T. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.022 · Cited by 3
High Doses of Vitamin C and Leukemia: In Vitro Update
Mastrangelo, D., Massai, L., Fioritoni, G., Lo‐Coco, F., Noguera, N. I., & Testa, U. (2018) · InTech eBooks · doi:10.5772/intechopen.71484 · Cited by 3
“which decline with differentiation [138].”
Huang, C.-H., & Chang, C. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.05.49 · Cited by 3
“In a study on pre-leukemic clonal hematopoiesis, the investigators also emphasized that adequate nutritional ascorbate might compensate TET activity insufficiency (25).”
BackgroundRondeau, V., Kalogeraki, M., Roland, L., Nader, Z. A., Gourhand, V., Bonaud, A., Lemos, J. P., Khamyath, M., Moulin, C., Schell, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.31.542899 · Cited by 3
“ERG (10-43) Fli1 (10-36) Etv2 (10-32) EWS:FLI1 (10-31) ETS1 (10-31) Down peaks in 1013/1013 vs WT WT +/1013 1013/1013 DOWN”
BackgroundInfluentialLipids, apolipoproteins, carbohydrates, and risk of hematological malignancies
Liu, Q., Wei, D., Hammar, N., Yang, Y., Feychting, M., Zhang, Z., Walldius, G., Smedby, K. E. E., & Fang, F. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01207-y · Cited by 2
Pan, S., Hong, Y., Jian, Y., Shen, P., Lu, X., Chen, Y., Lin, Y., Zha, S., Jiang, L., & Fang, X. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202500124 · Cited by 2
Zarakowska, E., Guz, J., Gackowski, D., & Oliński, R. (2025) · The World Journal of Men s Health · doi:10.5534/wjmh.250116 · Cited by 2
“Notably, hematopoietic stem cells have been identified to exhibit markedly high intra-cellular vitamin C (iVC) levels [54], analogous to that observed in prostate cells [33].”
Xu, L., Hu, X., Zhang, F., Zhou, S., Zhang, Z. L., Zhang, J., Liang, H., Liu, H., Chen, G., Zhang, Q., et al. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202501602 · Cited by 2
“Ascorbic acid (AA), also known as vitamin C, is a vital water-soluble vitamin required for collagen synthesis in the human body [1–5].”
The Link Between Vitamins and Hematopoiesis: A Stem Cell Perspective
Gonçalves, C. E. D. S., Santos, A. A., Sartori, T., da Silva, R. O., Vivian, G. K., de Matos, L. A., Neves, B. R. O., Casagrande, J. G., Fock, R. A., & Hastreiter, A. A. (2025) · Stem Cells and Development · doi:10.1177/15473287251400298 · Cited by 2
“55 Interestingly enough, it is well recognized that patients with leukemia have decreased serum levels of vitamin C, 56 underscoring yet again the importance of this metabolite in maintaining hematopoietic homeostasis.”
Vitamin C is essential for proper myogenic differentiation
Kondo, Y., Sato, A., Osakabe, N., Minowa, T., Hung, Y.-L., Machida, S., & Ishigami, A. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110704 · Cited by 2
Kalogeraki, M., Rondeau, V., Nader, Z. A., Espéli, M., & Balabanian, K. (2026) · iScience · doi:10.1016/j.isci.2026.114921 · Cited by 2
Mechanisms of Thrombocytosis in Iron‐Deficiency Anemia
Facco, J. V., Krause, D. S., & Saad, S. T. O. (2026) · European Journal Of Haematology · doi:10.1111/ejh.70211 · Cited by 2
“Additionally, iron-dependent epigenetic regulators such as TET2 may further modulate lineage commitment through effects on DNA hydroxymethylation [76], although this remains to be fully elucidated.”
Qiao, W., Wang, Y., Zhao, Z., Wang, Y., Chen, K., Zhao, Z., & Li, M. (2022) · RSC Advances · doi:10.1039/d2ra04146d · Cited by 2
Self-citationVitamin C in Health and Disease: From Redox Biology to Clinical Medicine
Li, Y. R. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55474-2_16 · Cited by 2
Canonico, B., Pricl, S., Biagiotti, S., Guescini, M., Barattini, C., Montanari, M., Panza, G., Lopez, D., Papa, S., & Klionsky, D. J. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_397 · Cited by 2
Aumailley, L., & Lebel, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311857 · Cited by 2
Witamina C w leczeniu nowotworów i profilaktyce chorób niezakaźnych
Kalemba-Drożdż, M. (2018) · Państwo i Społeczeństwo · doi:10.31749/pismzp2018/20848 · Cited by 2
Özcan, A., Saraçoğlu, S., Verboon, J. M., Karakükçü, M., Patıroğlu, T., Çoşkun, A., Sankaran, V. G., & Ünal, E. (2019) · American Journal of Hematology · doi:10.1002/ajh.25402 · Cited by 2
“It may be speculated that the scurvy should complicate the clinical course by worsening the pancytopenia and indeed recent work suggests that ascorbate may have a critical role in regulating hematopoietic stem cell function, as does the FA pathway.(3)”
BackgroundProperties, forms and biological effects of vitamin C in skin therapies
Wrocławiu, W. S. F. Z. S. W., & Janecka, A. (2023) · Aesthetic Cosmetology and Medicine · doi:10.52336/acm.2022.032 · Cited by 2
Joly, A., Schott, A., Phadke, I., González‐Menéndez, P., Kinet, S., & Taylor, N. N. (2024) · Physiology · doi:10.1152/physiol.00035.2024 · Cited by 2
Pan, P., & Wu, S. (2019) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(19)61175-8 · Cited by 2
L-Ascorbic Acid in the Epigenetic Regulation of Cancer Development and Stem Cell Reprogramming
Kovina, A. P., Petrova, N. V., Razin, S. V., & Kantidze, O. L. (2020) · Acta Naturae · doi:10.32607/actanaturae.11060 · Cited by 2
Genetic predisposition to myeloproliferative neoplasms implicates hematopoietic stem cell biologyPreprint
Bao, E. L., Nandakumar, S. K., Liao, X., Bick, A. G., Karjalainen, J. M., Tabaka, M., Gan, O. I., Havulinna, A. S., Kiiskinen, T., Lareau, C. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/790626 · Cited by 2
Wang, W., DeVilbiss, A., Villanueva, M. A., Mathews, T. P., Zhao, Z., Martin-Sandoval, M. S., Benegiamo, G., Awani, A., Goeminne, L. J. E., Dever, D. P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.05.450633 · Cited by 2
Self-citationHydrogen and Vitamin C Combination Therapy: A Novel Method of RadioprotectionPreprint
Miyakawa, M., Zhang, S., Behnan, J., Morganti, C., Ito, K., Isaksn, P., Miyakawa, A., & Uhlén, P. (2023) · Preprints.org · doi:10.20944/preprints202312.1369.v1 · Cited by 1
Lessons Learned from Cancer Metabolism for Physiology and DiseasePreprint
Campbell, S. L., & Christofk, H. R. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041554 · Cited by 2
van der Veer, B. K., Custers, C., Brangers, W., Cornelis, R., Tsaniras, S. C., Ridder, K. D., Thienpont, B., Cheng, H., Chen, Q., Kraushaar, D. C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656260 · Cited by 2
“5( 23, 24 ).”
Bjelosevic, S., Fauth, R., Do, B. T., Alexe, G., Merickel, L. A., Jackson, T. D., Basanthakumar, A. T., Taillon, A., Salhotra, S., Ryback, B. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661633 · Cited by 3
“Vitamin involvement in leukemo-genesis has been previously described; for instance, ascorbate (vitamin C) depletion can impair the function of the ten-eleven translocation (TET) methylcytosine dioxygenase TET2 and cooperate with FMS-like tyrosine kinase 3 (FLT3) mutations to drive AML 16-18 .”
Ishikawa, V. N., Gontijo, G. M., Ichikawa, A. I. T., Bubna, P., Conter, F. D. S., de Queiroz, A. C. M., Picchia, R. D., Nunes, B. M. M., & Cardillo, I. C. P. (2023) · International Journal of Nutrology · doi:10.54448/ijn23224 · Cited by 1
“In this scenario, metabolomics provides information on cellular pathways, observing substrates and metabolic products through different pathways [18,19] .”
BackgroundPaladino, D. M., Vidoto, J. A. F., Lopes, R. B., Idalgo, F. A., Cicareli, Á. J., & Kassis, E. N. (2024) · MedNEXT Journal of Medical and Health Sciences · doi:10.54448/mdnt24s108 · Cited by 1
Potentiation of Tumor Hallmarks by the Loss of GULO, a Vitamin C Biosynthesis Gene in Humans
Sekar, G., Bahot, A., Bansode, M., Phadnis, A., Sarode, S. C., & Sharma, N. K. (2024) · Current Molecular Medicine · doi:10.2174/0115665240328074241003110326 · Cited by 1
Effects of ascorbic acid on myelination in offspring of advanced maternal age
Yan, X., Jiang, C., Han, Z., Huang, D., Cheng, L., Han, W., & Jiang, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.019 · Cited by 1
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation
Willems, S., Maksumic, L., Niggenaber, J., Lin, T., Schulz, T., Weisner, J., Sievers, S., Müller, M. P., Summerer, D., & Rauh, D. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00042 · Cited by 1
Méndez-Durazno, C., Cisneros‐Pérez, P. A., Mogollón, N. G. S., Mora, J. R., Cuesta, S. A., Bailón-Moscoso, N., Romero-Benavides, J. C., Monge-Sevilla, R., Fernández, L., Romero‐Estévez, D., et al. (2025) · npj Science of Food · doi:10.1038/s41538-025-00503-x · Cited by 1
Ascorbic Acid Sensing Reveals Its Different Stability in Biological Media
Jin, J., Sun, Z., Yu, P., Liu, J., & Mao, L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c04271 · Cited by 1
Mitra, S., Kumar, A., Pandey, M., Gill, A., Sharma, M., Pundir, S., Jangir, M., & Chawla, G. (2025) · iScience · doi:10.1016/j.isci.2025.114296 · Cited by 6
Saitoh, Y., Tanimura, Y., Ueda, S., Furuhata, T., Takeda, M., Okawachi, K., & Fukukita, Y. (2026) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2026.130908 · Cited by 1
Clonal hematopoiesis and age-associated degenerative disorders
Chanias, I., Doulberis, M., & Bonadies, N. (2026) · Leukemia Research · doi:10.1016/j.leukres.2026.108180 · Cited by 1
Zhai, J., Li, H., Bao, J., Zhang, X., & Li, J. (2026) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2026.140147 · Cited by 1
Aging mechanisms and rejuvenation strategies for hematopoietic stem cells
Zhang, Y., Xu, Y., Shi, W., Cao, D., Guo, D.-A., & Yue, R. (2026) · Genome biology · doi:10.1186/s13059-026-04119-6 · Cited by 1
“Together, these multifaceted intrinsic and extrinsic alterations drive the characteristic aging phenotypes of HSCs. Figure created by BioRender leukemia cells can block aberrant self-renewal and delay disease progression by rectifying the epigenetic landscape [81, 82].”
Control of naive T cell reactivity and peripheral tolerance by ascorbate and TET activity
Hao, X., Bai, L., Li, J., Xu, B., Janke, L. J., Palacios, G., Guy, C. S., Crawford, J. C., Fan, Y., Rosikiewicz, W., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeh1439 · Cited by 1
Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level
Ye, Y., Zhang, H., Xin, Z., Sun, W., Liu, L., Xiong, M., Zhao, H., Zhang, Y., Geng, J., Zhao, L., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.06.006 · Cited by 1
Lu, J., Xue, Z., Zhao, X., 齐小辉, Qiao, L., Wu, C., & Kou, X. (2026) · Plant Science · doi:10.1016/j.plantsci.2026.113343 · Cited by 1
Mikkelsen, S. U., Al-Mousawi, A., Puglisi, A. B., Vallentin, A. P., Mortensen, A. Ø., Madaj, Z., Hinoue, T., Ottesen, H. N., Jespersen, J. S., Gillberg, L., et al. (2026) · Cancer · doi:10.1002/cncr.70549 · Cited by 2
“14 Notably, vitamin C deficiency is commonamongpatientswithhematologicalmalignancies.”
Vitamin C: Current Concepts in Human Physiology
Carr, A. C., & Natarajan, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-295-2 · Cited by 1
Al-Ansari, R. Y., Otaibi, D. A., Hudaithi, N. A., & Abdalla, L. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x211032066 · Cited by 1
Effect of Vitamin C on Cancer Process
HEMDAN, O. A. M., Girgin, G., & Baydar, T. (2024) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1484625 · Cited by 1
Recent studies on dynamics of vitamin C during some pathological injury models
Ji, W., Xue, Y., Yu, P., & Mao, L. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-0148 · Cited by 1
Pu, N., Liu, S., Bai, X., Yang, J., Qian, T., Wei, Z., Ma, T., Cai, L., & Wu, W. (2023) · Cancer Screening and Prevention · doi:10.14218/csp.2023.00001 · Cited by 1
Metabolic remodeling during murine early embryo developmentPreprint
Zhao, J., Yao, K., Yu, H., Zhang, L., Xu, Y., Hu, Z., Zhang, J., Chen, L., Sun, Z., Zhu, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-623821/v1 · Cited by 1
Self-citationWatanuki, S., Kobayashi, H., Sugiura, Y., Yamamoto, M., Karigane, D., Shiroshita, K., Sorimachi, Y., Fujita, S., Morikawa, T., Koide, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.16.532898 · Cited by 1
“In contrast, the number of transcripts regulated by PRMT1 decreased or was unchanged (Supplementary Figure 9), suggesting that the transcriptional regulatory function of PRMT1 is limited.”
BackgroundComazzetto, S., Cassidy, D. L., DeVilbiss, A., Jeffery, E. C., Ottesen, B. R., Reyes, A. R., Muh, S., Mathews, T. P., Chen, B., Zhao, Z., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.01.587574 · Cited by 1
Self-citationAkram, T., Luchtel, R. A., Dubey, V., Seal, S., Aggarwal, R. K., Sai, H., & Shenoy, N. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.21.655101 · Cited by 1
Papers of note in Nature 549 (7673)
VanHook, A. M. (2017) · Science Signaling · doi:10.1126/scisignal.aaq0229
Harjes, U. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.200
Examining the markers of vitamin C cytotoxicity in pancreatic ductal adenocarcinoma
Warren, C. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0377751
“For instance, vitamin C acts, as mentioned above, as a co-factor for TET dioxygenases and supplementation of vitamin C increases the function of TET dioxygenases [66-68].”
BackgroundI. Understanding the Pathogenesis of Acute Myeloid Leukemia through Leukemic Stem Cells
Kikushige, Y., & Miyamoto, T. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.1272
The aging hematopoietic stem cell niche
Heazlewood, S. Y., Nilsson, S. K., & Cao, B. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.06.001
Vitamin C Treatment Restores TET2 Deficiency and Confers Sensitivity to PARP Inhibition
Abdel-Wahab, O. I. (2017) · The Hematologist · doi:10.1182/hem.v14.6.7877
Therapeutic approaches for the treatment of aging-induced stem cell dysfunction
Bizzaro, D., Russo, F. P., & Burra, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00018-9
In Situ Silver-based Electrochemical Bioreactor In VivoPreprint
Huang, Y. D., Zhong, L., Deng, Z., Wu, P., He, J., Bai, Z., Zhong, Y. P., Peng, H., Zhang, K., Liang, X., et al. (2020) · doi:10.21203/rs.3.rs-103588/v1
Ratliff, B. B., Rabadi, M. M., & Celikoyar, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00004-4
Lü, Z., Xie, Y., Huang, H., Jiang, K., Zhou, B., Wang, F., & Chen, T. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3318940
Rundquist, O. (2021) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789179291044
High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases
Guo, G., Chen, Q., Luo, G., Meng, Z., Pan, L., Chen, P., & Drisko, J. (2022) · Life · doi:10.3390/life12030335 · Cited by 1
Rocha, M. S., de Aquino, L. L., de Oliveira, C. P., Salviano, J. L., Patrício, L. R., dos Santos, T. R., Lopes, V. B., Dias, W. C., Rodrigues, Á. T. D. S., & Filho, I. J. Z. (2022) · International Journal of Nutrology · doi:10.54448/ijn22s101
“In this scenario, metabolomics provides information on cellular pathways, observing substrates and metabolic products through different pathways [14,15].”
BackgroundFaculty Opinions recommendation of Lymph protects metastasizing melanoma cells from ferroptosis.
Dudley, A. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738515495.793578635
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.2
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.3
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.4
Ascorbic Acid Therapy in Hematological Malignancies - The Current Knowledge and Future DirectionsPreprint
Lam, W. K., Ha, C. Y., & Yip, S. F. (2022) · doi:10.32388/pmlz1t.5
Metadata
- Authors
- Agathocleous, M., Meacham, C. E., Burgess, R. J., Piskounova, E., Zhao, Z., Crane, G. M., Cowin, B. L., Bruner, E., Murphy, M. M., Chen, W., Spangrude, G. J., Hu, Z., DeBerardinis, R. J., & Morrison, S. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of Utah (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Morrison, Sean J.
- ORCID
- Venue
- Nature
- Published
- 2017-08-21
- Volume
- 549
- Issue
- 7673
- Pages
- 476-481
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5910063
- OpenAlex
- W2746373891
- Cited by
- 545
- References
- 58
- Citations by year
- 2026: 30 · 2025: 52 · 2024: 62 · 2023: 73 · 2022: 53 · 2021: 71 · 2020: 91 · 2019: 45 · 2018: 51 · 2017: 17
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Aging (R37AG024945)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100848)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- vitamin C, hematopoietic stem cells, leukemogenesis, TET2, dioxygenase, FLT3-ITD, hematopoietic progenitor cells, cellular metabolism, stem cell differentiation, myelopoiesis, tumour suppressor
- MeSH terms
- Animals, Ascorbic Acid, Ascorbic Acid Deficiency, DNA-Binding Proteins, Female, Hematopoietic Stem Cells, Humans, Leukemia, Male, Proto-Oncogene Proteins, Myelopoiesis, Dioxygenases, Mice, fms-Like Tyrosine Kinase 3, Metabolomics, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
